Royalty Pharma published press releases by date and/or category

Royalty Pharma to Present at Upcoming Investor Conferences

NEW YORK , NY,  February 09, 2023 - Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the months of February and March: SVB Securities Global Biopharma Conference on Thursday, February 16 at 10:40 a.m.

Royalty Pharma Announces Dividend Increase

NEW YORK, NY, January 9, 2023 - Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2023 of $0.20 per Class A share, reflecting a 5.3% increase in the company’s quarterly dividend over the previous quarter’s dividend.

Royalty Pharma Reports Third Quarter 2022 Results

NEW YORK , NY,  November 08, 2022  -  Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the third quarter of 2022 and raised full-year 2022 guidance for Adjusted Cash Receipts(1) (a non-GAAP financial measure).

Stay up to date

Subscribe to Royalty Pharma news and alerts